Staff Reporter (Healthcare, Law, Biotech)
Helen covers healthcare, law, insurance and biotechnology in the greater Valley region.
Phone: 818-316-3121 Extension: 112
MannKind Corp. in Westlake Village has issued 7.3 million shares to creditor Deerfield to pay down $7 million in debt, according to Securities and Exchange documents filed Friday.
Cure Pharmaceutical in Oxnard announced Wednesday that it has signed a term agreement for the acquisition of the non-pain assets of Therapix Biosciences Ltd., a clinical-stage pharmaceutical company that is developing cannabinoid-based medications.
Simulations Plus Inc. reported on Tuesday profits of $2.4 million for its third fiscal quarter.
COURTS: Judges can refer cases to Tarzana service for low-cost resolution.
Bar Association opens mediation center.
LIST: Seminars, classes, mentorships and webinars develop leadership style.
Female entrepreneurs discuss leadership styles.
Atara Biotherapeutics opens ATOM center in Thousand Oaks
Atara Biotherapeutics adds to its Conejo Valley presence with new building.
Amgen Inc. in Thousand Oaks has filed a lawsuit against drugmaker Intas Pharmaceuticals Inc. and its subsidiary Accord Healthcare Inc. over its plans to manufacture a generic of Amgen’s medication Sensipar.
Blackline Inc. in Woodland Hills has announced the appointment of an executive to oversee the company’s expansion into the Asia-Pacific region.
The Los Angeles. City Council has unanimously passed a resolution urging Kaiser Permanente not to cut 306 jobs in Los Angeles, including 34 positions at a laboratory in North Hollywood.